You have 9 free searches left this month | for more free features.

rGBM

Showing 1 - 25 of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)

Recruiting
  • Glioma
  • +7 more
  • Laparoscopically harvested omental tissue autograft
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 31, 2023

Glioblastoma, Adult Trial in Cleveland (Pembrolizumab at 7 days prior, Pembrolizumab at 14 days post, Pembrolizumab at 35 days

Recruiting
  • Glioblastoma, Adult
  • Pembrolizumab at 7 days prior
  • +3 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 17, 2023

Recurrent Glioblastoma Trial (Niraparib, Re-irradiation (re-RT))

Not yet recruiting
  • Recurrent Glioblastoma
  • (no location specified)
Dec 23, 2022

Recurrent Glioblastoma Trial in United States (Carboplatin, Exablate BBBD)

Recruiting
  • Recurrent Glioblastoma
  • Palo Alto, California
  • +3 more
Nov 30, 2021

Recurrent Glioblastoma Trial in Worldwide (Exablate BBBD, Carboplatin)

Recruiting
  • Recurrent Glioblastoma
  • Toronto, Ontario, Canada
  • +3 more
Dec 6, 2021

Glioblastoma, Recurrent Glioblastoma Trial in Boston (Pembrolizumab, Olaparib, Temozolomide)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Boston, Massachusetts
  • +2 more
Jul 14, 2022

Glioblastoma, Glioblastoma Multiforme, Glioblastoma Multiforme, Adult Trial in Phoenix (Pamiparib, Olaparib, Radiation therapy)

Recruiting
  • Glioblastoma
  • +2 more
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
May 3, 2022

Recurrent Glioblastoma Trial in Beijing (ASC40 tablets, Placebo tablets, Bevacizumab)

Recruiting
  • Recurrent Glioblastoma
  • ASC40 tablets
  • +2 more
  • Beijing, Beijing, China
    Beijing Tiantan Hospital,Capital Medical University
Jun 28, 2022

Recurrent Glioblastoma Trial (MTX110, Programmable pump and catheter system, Lomustine)

Recruiting
  • Recurrent Glioblastoma
  • Jacksonville, Florida
  • +1 more
Jan 26, 2023

Glioblastoma Trial (CM93)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Jun 17, 2021

Recurrent Glioblastoma, Glioblastoma - Category Trial in Edmonton (Repeat Surgical Management of Recurrent GBM)

Recruiting
  • Recurrent Glioblastoma
  • Glioblastoma - Category
  • Repeat Surgical Management of Recurrent GBM
  • Edmonton, Alberta, Canada
    University of Alberta Division of Neurosurgery
Apr 5, 2022

Oncology Trial in Luxembourg (Personalized Functional Profiling)

Recruiting
  • Oncology
  • Personalized Functional Profiling
  • Luxembourg, Luxembourg
  • +1 more
Feb 23, 2022

Recurrent Glioblastoma Trial in Taoyuan (NaviFUS System)

Recruiting
  • Recurrent Glioblastoma
  • NaviFUS System
  • Taoyuan, Taiwan
    Chang Gung Medical Foundation
Sep 23, 2021

Recurrent Glioblastoma Trial in Tianjin (Niraparib)

Recruiting
  • Recurrent Glioblastoma
  • Tianjin, Tianjin, China
    Tianjin Huanhu Hosptal
Jan 18, 2021

GBM Trial (Lenvatinib, Pembrolizumab, Tumor Treating Fields (TTFields))

Not yet recruiting
  • GBM
  • (no location specified)
Aug 2, 2023

Glioblastoma, Recurrent Glioblastoma Trial in Iowa City (Static Magnetic and Electric (sBE) device, Lomustine, Bevacizumab)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Static Magnetic and Electric (sBE) device
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Sep 20, 2022

Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

Recruiting
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

Recurrent Glioblastoma Trial (Atezolizumab)

Not yet recruiting
  • Recurrent Glioblastoma
  • (no location specified)
Oct 3, 2023

Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

Recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • CYNK-001 systemic and Intra cavity administration
  • Duarte, California
  • +5 more
Jan 20, 2023

Recurrent Glioblastoma Trial in Beijing (Combined stereotactic radiosurgery and enhanced immunotherapy)

Recruiting
  • Recurrent Glioblastoma
  • Combined stereotactic radiosurgery and enhanced immunotherapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Nov 16, 2021

Recurrent Glioblastoma Multiforme Trial in Beijing (SNC-109 CAR-T Cells)

Recruiting
  • Recurrent Glioblastoma Multiforme
  • SNC-109 CAR-T Cells
  • Beijing, China
    Chinese PLA General Hospital
May 11, 2023

Malignant Glioma Trial in United States (PVSRIPO)

Active, not recruiting
  • Malignant Glioma
  • PVSRIPO
  • San Francisco, California
  • +5 more
Jun 28, 2022

Glioblastoma Multiforme Trial in Baltimore (Dichloroacetate (DCA), Genotype)

Not yet recruiting
  • Glioblastoma
  • Baltimore, Maryland
    Johns Hopkins University
Dec 10, 2021

Glioblastoma, Recurrent Glioblastoma, Supratentorial Glioblastoma Trial in United States (lerapolturev, pembrolizumab)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • lerapolturev
  • pembrolizumab
  • San Francisco, California
  • +9 more
Nov 30, 2021

Glioblastoma Multiforme, Glioblastoma, Glioma Trial in Taoyuan City (NaviFUS System, Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • +5 more
  • Taoyuan City, Taiwan
    Linkou Chang Gung Memorial Hospital
Aug 2, 2021